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The interpretation of results from molecular epidemiology is fraught with diYculties, 8 however, and Porta and colleagues considered several theories to explain their findings. 2 We would like to highlight two possible explanations for the apparent paradox. Firstly, coVee may have a diVerent impact on the aetiology of distinct types of clinically similar pancreatic cancer. Secondly, the distribution of mutations found in the tumour at diagnosis may not be representative of the mutations that are causally related to the cancer.
Thus, if coVee drinking increases the risk of pancreatic cancer with K-ras mutations, but reduces the risk of cancer without these mutations (the "wild type"), no overall relation may appear between coVee and pancreatic cancer. To show this mathematically, consider a population with the proportion of coVee drinkers equal to c. Let the absolute risk of the cancer with K-ras mutations in persons who do not drink coVee be P K-ras . The corresponding absolute risk of the cancer with a wild type gene is P wild. Let r K-ras be the relative risk for the cancer with the K-ras mutations for a coVee drinker compared with a person who does not drink coVee. The analogous relative risk for the wild type cancer is r wild . Then the two types of cancer will be represented by the following population fractions:
The odds ratio for a cancer with K-ras mutations, considering cancer cases only, is simply:
as previously shown in a more general context. 9 The overall relative risk (RR) of pancreatic cancer with regard to coVee drinking in the whole population, disregarding type of cancer is:
or From the data presented by Porta and colleagues, we can estimate P K-ras /P wild as 10/8=1.25. If we assume that the odds ratio r K-ras /r wild among cases is 3.7 (in accordance with the data presented by Porta and colleagues), 2 several combinations of r K-ras and r wild are compatible with an overall relative risk around 1.0 (table 1). If we imagine that coVee drinking is rather weakly positively associated with cancer with K-ras mutations (r K-ras =1.5) and more strongly inversely associated with cancer with the wild type (r wild =0.41), the overall relative risk can be practically 1.0. Thus, the results presented by Porta and colleagues 2 are consistent with an overall lack of association between coVee drinking and the risk of pancreatic cancer.
On the other hand, if K-ras mutations constitute an important step in the early stage carcinogenesis, 3 examining the tumour at the clinical stage may be too late for evaluating the role of mutations in the aetiology. Many changes, not related to the aetiology, may already have taken place in the tumour cell. 8 CoVee may even facilitate the persistence of the K-ras mutations at a later stage, without influencing the risk of initiation or the complete cancer development.
It is therefore of interest to examine the prevalence of K-ras mutations in normal pancreatic tissue according to coVee consumption. Berger and colleagues recently did an analysis of this kind for cigarette smoking, and found K-ras mutations in non-neoplastic pancreas only in heavy cigarette smokers. 10 This is apparently inconsistent with the Spanish cancer data indicating a lower prevalence of K-ras mutations in cigarette smokers. 2 As cigarette smoking is an established risk factor for pancreatic cancer, 3 Berger and colleagues were of the opinion that their results reflected a causal link.
K-ras mutations are also found in several non-malignant pancreatic conditions and may thus be a general indicator of a pathological process in the pancreas. 10 If no association is found between coVee consumption and K-ras mutations among people aVected with other diseases, the hypothesis that there is a complex causal relation with pancreatic cancer becomes more plausible. Thus, studies of relations between coVee consumption and mutation prevalence are called for in, for example, chronic pancreatitis.
In the years to come, we shall see many studies in molecular epidemiology following the general approach of Porta and colleagues. At present, it may not be easy to generate data that can throw suYcient light on the theories put The estimates of the odds ratio (3.7) and P K-ras /P wild (1.25) are as found by Porta and colleagues.
